Twinbeech Capital »

Catalyst Pharmaceutical Partners shares owned by Twinbeech Capital

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Twinbeech Capital from 13F filings

Historical chart of Twinbeech Capital investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Twinbeech Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Twinbeech Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 34k 31.43
2023-09-30 $2.5M 214k 11.69
2023-06-30 $318k 24k 13.44
2023-03-31 $2.0M 122k 16.58

More positions owned by Twinbeech Capital

Cme (CME)
Hilton Worldwide Holdings (HLT)
Boston Scientific Corporation (BSX)
Intercontinental Exchange (ICE)
Rollins (ROL)
Blackrock (BLK)
Howmet Aerospace (HWM)
Ss&c Technologies Holding (SSNC)
ON Semiconductor (ON)
WESCO International (WCC)
Five Below (FIVE)
Hewlett Packard Enterprise (HPE)
Burlington Stores (BURL)
McKesson Corporation (MCK)
Lauder Estee Cos Cl A (EL)

View all positions for Twinbeech Capital

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners